References

  1. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller A, Gargalianos P, d? Arminio Monforte A, Yust I, Bruun JN, Phillips AN, and Lundgren JD. Changing patterns of mortality across Europe in patients infected with HIV- EuroSIDA Study Group Lancet. 1998; 352 (9142): 1725-1730. PubMed | Google Scholar

  2. UNAIDS. World AIDS Day report. 2011. Google Scholar

  3. Bongaarts J. Human population growth and the demographic transition. Philosophical Transactions of Royal Society B Biological Science. 2009; 364 (1532): 2985-2990. PubMed | Google Scholar

  4. Bocquier P, Madise NJ, and Zulu EM. Is there an urban advantage in child survival in sub-saharan Africa? Evidence from 18 countries in the 1990s. Demography. 2011; 48 (2): 531-558. PubMed | Google Scholar

  5. Kyobutungi C, Ziraba A K, Ezeh A, and Yé Y. The burden of disease profile of residents of Nairobi's slums: Results from a Demographic Surveillance System. Population Health Metrics. 2008; 6(1): 1. PubMed | Google Scholar

  6. Riley L W, Ko A I, Unger A, and Reis M G. Slum health: Diseases of neglected populations. BMC International Health and Human Rights. 2007;7(2). PubMed | Google Scholar

  7. Unge C, Södergĺrd B, Marrone G, Thorson A, Lukhwaro A, Carter J, Ilako F, and Ekström A M. Long-Term Adherence to Antiretroviral Treatment and Program Drop-Out in a High-Risk Urban Setting in Sub-Saharan Africa: A Prospective Cohort Study. PLoS ONE. 2010; 5(10): e13613. PubMed | Google Scholar

  8. NTV Kenya. Sisters of Death. CARE for AIDS. 2013. Google Scholar

  9. Mutisya M, Yarime M. Understanding the Grassroots Dynamics of Slums in Nairobi: The Dilemma of Kibera Informal Settlements. International Transaction Journal of Engineering, Management & Applied Sciences & Technologies. 2011; 2 (2): 197-213. PubMed | Google Scholar

  10. How soon after HIV seroconversion is antiretroviral therapy initiated?. The UK Register of HIV Seroconverters Steering Committee. AIDS London England. 1999; 13 (10): 1241-1247. PubMed | Google Scholar

  11. Fordyce J E, Singh T P, Nash D, Gallagher B and Forlenza S. Survival Rates in NYC in the Era of Combination ART. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2002; 30 (1): 111-118. PubMed | Google Scholar

  12. National AIDS and STI Control Programme and MoH Kenya. Kenya AIDS Indicator Survey 2012 . Preliminary Report. 2012. Google Scholar

  13. Karanja M. Kenya: Myth Shattered - Kibera Numbers Fail to Add Up. The Nation (Nairobi). 2010. Google Scholar

  14. WHO. Scaling up antiretroviral therapy in resource-limited settings: Treatment guidelines for a public health approach. WHO. 2003. PubMed | Google Scholar

  15. Kaplan E L and Meier P. Nonparametric Estimation from Incomplete Observations. Journal of American Statistical Association. 1958; 53 (282): 457. PubMed | Google Scholar

  16. Egger M, May M, Chęne G, Phillips A N, Ledergerber B, Dabis F, Costagliola D, D'Arminio Monforte A, de Wolf F, Reiss P, Lundgren J D, Justice A C, Staszewski S, Leport C, Hogg R S, Sabin C A, Gill M J, Salzberger B, Sterne J A C and ART Cohort Collaboration. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet. 2002; 360 (9327): 119-129. PubMed | Google Scholar

  17. May M, Boulle A, Phiri S, Messou E, Myer L, Wood R, Keiser O, Sterne J A C, Dabis F, Egger M and IeDEA Southern Africa and West Africa. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes. Lancet. 2010; 376 (9739): 449-457. PubMed | Google Scholar

  18. Suely H Tuboi, Mauro S. Mortality During the First Year of Potent Antiretroviral Therapy in HIV-1-Infected Patients in 7 Sites Throughout Latin America and the Caribbean. JAIDS Journal of Acquired Immune Deficiency Syndrome. 2009; 51(5): 615-623. PubMed | Google Scholar

  19. Hambisa M T, Ali A and Dessie Y. Determinants of Mortality among HIV Positives after Initiating Antiretroviral Therapy in Western Ethiopia: A Hospital-Based Retrospective Cohort Study. ISRN AIDS. 2013; 2013. Google Scholar

  20. Alemu A W and Sebastián M S. Determinants of survival in adult HIV patients on antiretroviral therapy in Oromiyaa, Ethiopia. Global Health Action. 2010; 3. Google Scholar

  21. Biadgilign S, Reda A A and Digaffe T. Predictors of mortality among HIV infected patients taking antiretroviral treatment in Ethiopia: a retrospective cohort study. AIDS Res Ther. 2012; 9 (1): 15. PubMed | Google Scholar

  22. Mills E J, Bakanda C, Birungi J, Mwesigwa R, Chan K, Ford N, Hogg R S and Cooper C. Mortality by baseline CD4 cell count among HIV patients initiating antiretroviral therapy: evidence from a large cohort in Uganda. AIDS London England. 2011; 25 (6): 851-855. PubMed | Google Scholar

  23. Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S and Harries A D. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS London England. 2006; 20 (18): 2355-2360. PubMed | Google Scholar

  24. Sieleunou I, Souleymanou M, Schönenberger A M, Menten J and Boelaert M. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North Province, Cameroon. Trop Med Int Health TM IH. 2009; 14 (1): 36-43. PubMed | Google Scholar

  25. Brinkhof M W G, Boulle A, Weigel R, Messou E, Mathers C, Orrell C, Dabis F, Pascoe M, Egger M and for the International epidemiological Databases to Evaluate AIDS (IeDEA). Mortality of HIV-Infected Patients Starting Antiretroviral Therapy in Sub-Saharan Africa: Comparison with HIV-Unrelated Mortality. PLoS Med. 2009; 6 (4): e1000066. PubMed | Google Scholar

  26. Mzileni M O, Longo-Mbenza B and Chephe T J. Mortality and causes of death in HIV-positive patients receiving antiretroviral therapy at Tshepang Clinic in Doctor George Mukhari Hospital. Pol Arch Med Wewnetrznej. 2008; 118 (10): 548-554. PubMed | Google Scholar

  27. Nurilign A, Kassahun A, Tadesse A and Amanuel A A. Predictors of mortality among HIV positive adults on antiretroviral therapy in Debremarkos Referral Hospital, Northwest Ethiopia. Journal of AIDS and HIV Research. 2014; 6 (1): 19-27. PubMed | Google Scholar

  28. Jerene D, Endale A, Hailu Y and Lindtjřrn B. Predictors of early death in a cohort of Ethiopian patients treated with HAART. BMC Infect Dis. 2006; 6 (1): 136. PubMed | Google Scholar

  29. Lawn S D, Myer L, Orrell C, Bekker L G and Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS London England. 2005; 19 (18): 2141-2148. PubMed | Google Scholar

  30. Amuron B, Levin J, Birunghi J, Namara G, Coutinho A, Grosskurth H and Jaffar S. Mortality in an antiretroviral therapy programme in Jinja, south-east Uganda: a prospective cohort study. AIDS Res Ther. 2011; 8 (1): 39. PubMed | Google Scholar